Inventor · disambiguated record
Jason Michael Gehrke
Also filed as: GEHRKE JASON MICHAEL
7 granted patents·19 pending applications·15 citations·filing 2015–2024
76Inventor score
Top patents by PatentIndex Score
26 records- 0192US11155803B2Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Granted Oct 26, 2021·13 cites·30 claims
- 0281US11725228B2Methods for detecting site-specific and spurious genomic deamination induced by base editing technologiesMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Aug 15, 2023·1 cites·11 claims
- 0378US12133884B2Methods of substituting pathogenic amino acids using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2019·Granted Nov 5, 2024·1 cites·4 claims
- 0476US2025108098A1Methods of substituting pathogenic amino acids using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0576US2024132867A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0673US2024076713A1Methods for Detecting Site-Specific and Spurious Genomic Deamination Induced by Base Editing TechnologiesMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 0770US12286641B2Methods for increasing efficiency of nuclease-induced homology-directed repairMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Apr 29, 2025·0 cites·6 claims
- 0868US2022275356A1Base editors with improved precision and specificityMASSACHUSETTS GEN HOSPITAL·Filed 2022·Application pending·0 cites
- 0967US2024252550A1Genetic modification of hepatocytesBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1066US2025090585A1Modified regulatory t cells and methods of using the sameBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1162US2024335516A1Compositions and methods for the treatment of spinal muscular atrophy (sma)BEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1260US11326157B2Base editors with improved precision and specificityMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted May 10, 2022·0 cites·21 claims
- 1359US2024287453A1Persistent allogeneic modified immune cells and methods of use thereofBEAM THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1455US2022170027A1Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1554US11021718B2Methods for increasing efficiency of nuclease-induced homology-directed repairMASSACHUSETTS GEN HOSPITAL·Filed 2015·Granted Jun 1, 2021·0 cites·14 claims
- 1652US2022098593A1Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1752US2022098572A1Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editorsBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1852US2022136012A1Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequenceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1950US2022313799A1Compositions and methods for editing a mutation to permit transcription or expressionBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2048US12454694B2Compositions and methods for improving base editingBEAM THERAPEUTICS INC·Filed 2019·Granted Oct 28, 2025·0 cites·17 claims
- 2147US2023140953A1Methods of editing a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic diseaseBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2246US2021380955A1Methods of editing single nucleotide polymorphism using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2346US2023159956A1Methods of editing single nucleotide polymorphism using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2443US2022387622A1Methods of editing a single nucleotide polymorphism using programmable base editor systemsBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2543US2020172899A1Epigenetically Regulated Site-Specific NucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 2640US2022133790A1Modified immune cells having enhanced anti-neoplasia activity and immunosuppression resistanceBEAM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Michael Gehrke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →